Run‐Cong Nie

1.7k total citations
79 papers, 947 citations indexed

About

Run‐Cong Nie is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, Run‐Cong Nie has authored 79 papers receiving a total of 947 indexed citations (citations by other indexed papers that have themselves been cited), including 47 papers in Pulmonary and Respiratory Medicine, 30 papers in Oncology and 24 papers in Surgery. Recurrent topics in Run‐Cong Nie's work include Gastric Cancer Management and Outcomes (39 papers), Metastasis and carcinoma case studies (25 papers) and Gastrointestinal Tumor Research and Treatment (20 papers). Run‐Cong Nie is often cited by papers focused on Gastric Cancer Management and Outcomes (39 papers), Metastasis and carcinoma case studies (25 papers) and Gastrointestinal Tumor Research and Treatment (20 papers). Run‐Cong Nie collaborates with scholars based in China, United States and United Kingdom. Run‐Cong Nie's co-authors include Shuqiang Yuan, Yuanfang Li, Ying-Bo Chen, Xiao‐Jiang Chen, Muyan Cai, Zhiwei Zhou, Shi Chen, Yongming Chen, Dan Xie and Jin‐Ling Duan and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and Nature Cell Biology.

In The Last Decade

Run‐Cong Nie

76 papers receiving 941 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Run‐Cong Nie China 18 439 336 248 230 195 79 947
Shuqiang Yuan China 20 609 1.4× 418 1.2× 275 1.1× 423 1.8× 355 1.8× 70 1.2k
Yangsoon Park South Korea 20 390 0.9× 475 1.4× 301 1.2× 279 1.2× 159 0.8× 59 1.2k
Chi‐Young Jeong South Korea 20 412 0.9× 393 1.2× 446 1.8× 212 0.9× 147 0.8× 58 1.1k
Akitaka Makiyama Japan 17 412 0.9× 715 2.1× 154 0.6× 193 0.8× 74 0.4× 116 994
Seung‐Hoon Beom South Korea 17 361 0.8× 459 1.4× 230 0.9× 150 0.7× 110 0.6× 69 901
Hisatoshi Nakagawara Japan 21 341 0.8× 517 1.5× 485 2.0× 211 0.9× 122 0.6× 68 1.1k
Hideto Fujita Japan 21 508 1.2× 584 1.7× 402 1.6× 417 1.8× 184 0.9× 95 1.3k
Jinning Ye China 15 323 0.7× 246 0.7× 187 0.8× 327 1.4× 264 1.4× 35 863
Tomoyoshi Takayama Japan 16 462 1.1× 464 1.4× 401 1.6× 401 1.7× 180 0.9× 43 1.2k
Mustapha Tehfé Canada 17 656 1.5× 699 2.1× 241 1.0× 186 0.8× 145 0.7× 90 1.1k

Countries citing papers authored by Run‐Cong Nie

Since Specialization
Citations

This map shows the geographic impact of Run‐Cong Nie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Run‐Cong Nie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Run‐Cong Nie more than expected).

Fields of papers citing papers by Run‐Cong Nie

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Run‐Cong Nie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Run‐Cong Nie. The network helps show where Run‐Cong Nie may publish in the future.

Co-authorship network of co-authors of Run‐Cong Nie

This figure shows the co-authorship network connecting the top 25 collaborators of Run‐Cong Nie. A scholar is included among the top collaborators of Run‐Cong Nie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Run‐Cong Nie. Run‐Cong Nie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nie, Run‐Cong, Xiaojiang Chen, Chengcai Liang, et al.. (2025). Safety and efficacy of perioperative dual PD-1 and HER2 blockade in HER2-positive gastric cancer. Cell Reports Medicine. 6(6). 102190–102190. 1 indexed citations
2.
Jia, Yi, Jiao Du, Xue Chen, et al.. (2025). A circRNA–mRNA pairing mechanism regulates tumor growth and endocrine therapy resistance in ER-positive breast cancer. Proceedings of the National Academy of Sciences. 122(8). e2420383122–e2420383122. 4 indexed citations
3.
Nie, Man, Zhou Liu, Peng Huang, et al.. (2025). Cardiomyocyte-localized CCDC25 senses NET DNA to promote doxorubicin cardiotoxicity by activating autophagic flux. Nature Cancer. 6(8). 1400–1418. 5 indexed citations
4.
5.
Zheng, Zi‐Qi, Xiao‐Jiang Chen, Run‐Cong Nie, et al.. (2024). Hyperactivation of mTOR/eIF4E Signaling Pathway Promotes the Production of Tryptophan‐To‐Phenylalanine Substitutants in EBV‐Positive Gastric Cancer. Advanced Science. 11(35). e2402284–e2402284. 3 indexed citations
6.
Nie, Run‐Cong, Ya Ding, Shuqiang Yuan, et al.. (2024). Perioperative PD-1 antibody tislelizumab plus chemotherapy for locally advanced gastro-oesophageal junction cancer: A prospective, nonrandomized, open-label, phase II trial.. Journal of Clinical Oncology. 42(16_suppl). 4083–4083. 1 indexed citations
7.
Zhang, Feiyang, et al.. (2024). First-line immune checkpoint inhibitors in low programmed death-ligand 1-expressing population. Frontiers in Pharmacology. 15. 1377690–1377690. 3 indexed citations
8.
Yuan, Shuqiang, Run‐Cong Nie, Yingbo Chen, et al.. (2023). Residual circulating tumor DNA after adjuvant chemotherapy effectively predicts recurrence of stage II‐III gastric cancer. Cancer Communications. 43(12). 1312–1325. 13 indexed citations
9.
Chen, Guoming, Hui Xie, Rong Zhang, et al.. (2023). Preoperative diagnosis of metastatic lymph nodes by CT-histopathologic matching analysis in gastric adenocarcinoma using dual-layer spectral detector CT. European Radiology. 33(12). 8948–8956. 9 indexed citations
10.
Li, Yuanfang, Shuqiang Yuan, Ying-Bo Chen, et al.. (2023). Evaluating relapse-free survival as an endpoint for overall survival in adjuvant immunotherapy trials. JNCI Journal of the National Cancer Institute. 115(9). 1085–1091. 7 indexed citations
11.
Nie, Run‐Cong, et al.. (2023). Association between Early Immune-Related Adverse Events and Survival in Patients Treated with PD-1/PD-L1 Inhibitors. Journal of Clinical Medicine. 12(3). 736–736. 12 indexed citations
12.
Zhou, Jie, Run‐Cong Nie, Yixin Yin, et al.. (2022). Genomic Analysis Uncovers the Prognostic and Immunogenetic Feature of Pyroptosis in Gastric Carcinoma: Indication for Immunotherapy. Frontiers in Cell and Developmental Biology. 10. 906759–906759. 7 indexed citations
13.
Lu, Lianghe, Zhangping He, Run‐Cong Nie, et al.. (2022). C-Reactive Protein Levels Predict Responses to PD-1 Inhibitors in Hepatocellular Carcinoma Patients. Frontiers in Immunology. 13. 808101–808101. 29 indexed citations
14.
Li, Changhua, Xiaojiang Chen, Guoming Chen, et al.. (2022). Development and verification of a nomogram for predicting the prognosis of resectable gastric cancer with outlet obstruction. BMC Cancer. 22(1). 1154–1154. 2 indexed citations
15.
Duan, Jin‐Ling, Wei Chen, Juanjuan Xie, et al.. (2022). A novel peptide encoded by N6-methyladenosine modified circMAP3K4 prevents apoptosis in hepatocellular carcinoma. Molecular Cancer. 21(1). 93–93. 109 indexed citations
16.
Deng, Zijian, Run‐Cong Nie, Jun Lü, et al.. (2021). Survival analysis of stage II gastric cancer patients after D2 gastrectomy: a Chinese people-based research. BMC Gastroenterology. 21(1). 363–363. 2 indexed citations
17.
Nie, Run‐Cong, Yun Wang, Jie Zhou, et al.. (2021). Efficacy of Anti-PD-1/PD-L1 Monotherapy or Combinational Therapy in Patients Aged 75 Years or Older: A Study-Level Meta-Analysis. Frontiers in Oncology. 11. 538174–538174. 19 indexed citations
18.
Li, Shuman, Jie Zhou, Yun Wang, et al.. (2020). Recent Findings in the Posttranslational Modifications of PD-L1. Journal of Oncology. 2020. 1–7. 17 indexed citations
19.
Chen, Shi, Xijie Chen, Run‐Cong Nie, et al.. (2018). A nomogram to predict prognosis for gastric cancer with peritoneal dissemination. Chinese Journal of Cancer Research. 30(4). 449–459. 13 indexed citations
20.
Chen, Shi, Run‐Cong Nie, Yuanfang Li, et al.. (2017). Body mass index (BMI) may be a prognostic factor for gastric cancer with peritoneal dissemination. World Journal of Surgical Oncology. 15(1). 52–52. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shuqiang Yuan Breakdown of academic impact, for papers by Yangsoon Park Breakdown of academic impact, for papers by Chi‐Young Jeong Breakdown of academic impact, for papers by Akitaka Makiyama Breakdown of academic impact, for papers by Seung‐Hoon Beom Breakdown of academic impact, for papers by Hisatoshi Nakagawara Breakdown of academic impact, for papers by Hideto Fujita Breakdown of academic impact, for papers by Jinning Ye Breakdown of academic impact, for papers by Tomoyoshi Takayama Breakdown of academic impact, for papers by Mustapha Tehfé
Rankless by CCL
2026